MARISSA QUIRK: Open Payments
NPI 1467182816 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 46 payments from 10 companies in 2025. Trend: 2023 $424 · 2024 $727 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $360 |
| Exact Sciences Corporation | 5 | $156 |
| Novo Nordisk Inc | 8 | $145 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Lilly USA, LLC | 2 | $43 |
| TOLMAR, INC. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Cologuard Collection Kit, VRAYLAR, QULIPTA, UBRELVY, ABILIFY MAINTENA, Rybelsus, Wegovy, MOUNJARO.
Industry payments across RI — which companies pay providers there.
